FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Omar Ali

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Anatomy

3T3-L1 Cells

Devices

Co-author Network

Publications

TOP 3
Yi Zhang; Michael Olivier; David L Rainwater; Reham M Abdou; Omar Ali; John Blangero; Ulrich Broeckel; Melanie A Carless; Diana Cerjak; Anthony Comuzzie; Joanne E Curran; Thomas D Dyer; Harald H H Göring; Jack W Kent; Ahmed H Kissebah
A comprehensive analysis of adiponectin QTLs using SNP association, SNP cis-effects on peripheral blood gene expression and gene expression correlation identified novel metabolic syndrome (MetS) genes with potential role in carcinogenesis and systemic inflammation.
Yi Zhang; Adam Lee; Michael Olivier; Omar Ali; John Blangero; Melanie A Carless; Diana Cerjak; Robert Diasio; Jack W Kent; Ahmed H Kissebah
Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a northern european family population.
Omar Ali; David Wyatt
Therapy of growth disorders.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Omar Ali (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yi Zhang; Michael Olivier; David L Rainwater; Reham M Abdou; Omar Ali; John Blangero; Ulrich Broeckel; Melanie A Carless; Diana Cerjak; Anthony Comuzzie; Joanne E Curran; Thomas D Dyer; Harald H H Göring; Jack W Kent; Ahmed H Kissebah
A comprehensive analysis of adiponectin QTLs using SNP association, SNP cis-effects on peripheral blood gene expression and gene expression correlation identified novel metabolic syndrome (MetS) genes with potential role in carcinogenesis and systemic inflammation.
BMC medical genomics 2013;6():14.
2013: Yi Zhang; Adam Lee; Michael Olivier; Omar Ali; John Blangero; Melanie A Carless; Diana Cerjak; Robert Diasio; Jack W Kent; Ahmed H Kissebah
Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a northern european family population.
BMC medical genomics 2013;6():9.
2011: Omar Ali; David Wyatt
Therapy of growth disorders.
Current opinion in endocrinology, diabetes, and obesity 2011;18(1):3-8.
2009: Omar Ali; Colleen McCann
A 16-year-old male with lower extremity dermopathy.
Journal of pediatric endocrinology & metabolism : JPEM 2009;22(6):481-2.
2009: Ghufran S Babar; Omar Ali; Elaine Parton; Raymond G Hoffmann; Ramin Alemzadeh
Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes.
Diabetes technology & therapeutics 2009;11(3):131-7.
2007: Omar Ali; Melanie Shim; Eileen Fowler; Marcia Greenberg; Donna Perkins; William Oppenheim; Pinchas Cohen
Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study.
The Journal of clinical endocrinology and metabolism 2007;92(3):932-7.
2007: Hae Soon Kim; Omar Ali; Melanie Shim; Kuk-Wha Lee; Patricia Vuguin; Radhika Muzumdar; Nir Barzilai; Pinchas Cohen
Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo.
Pediatric research 2007;61(2):159-64.
2007: Omar Ali; Melanie Shim; Eileen Fowler; Pinchas Cohen; William Oppenheim
Spinal bone mineral density, IGF-1 and IGFBP-3 in children with cerebral palsy.
Hormone research 2007;68(6):316-20.
2007: Omar Ali; Swati Banerjee; Daniel Kelly; Phillip Dk Lee
Management of type 2 diabetes mellitus associated with pituitary gigantism.
Pituitary 2007;10(4):359-64.
2003: Omar Ali; Pinchas Cohen
Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy.
Hormone research 2003;60 Suppl 3():115-23.